The real question is no longer if we are burned out, but why we are burning out faster and more universally than ever before.

The dosimetry market is valued at USD 3.28 billion in 2025 and is slated to exhibit USD 5.1 billion by 2035, which shows a ...

The research team tested the therapy in a small group of 18 patients with recurrent glioblastoma in a phase 1 clinical trial, which primarily examines the treatment’s safety profile. Related Content.